Christopher M Booth
2014
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Christopher M Booth trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Christopher M Booth's perspective
Ordered by how strongly the researchers Christopher M Booth trusts endorse each paper. Same corpus, a different order for every researcher.
- Time trends and local variation in primary treatment of localized prostate cancer. (Journal of Clinical Oncology)
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
- Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. (Journal of Clinical Oncology)
- J OURNAL OF C LINICAL O NCOLOGY Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
- Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. (Journal of the American Medical Association (JAMA))
- Risk of ischemic heart disease in women after radiotherapy for breast cancer. (New England Journal of Medicine)
- Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer. (Journal of Clinical Oncology)
- Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an… (Journal of Clinical Oncology)
- Hospital volume and surgical mortality in the United States. (New England Journal of Medicine)
- Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. (The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists)